PDMR Notification RSU Vesting
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PDMR Notifications
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases, announces that awards of restricted share units ("RSUs") granted by PureTech on 18 May 2022 to certain directors and other persons discharging managerial responsibilities ("PDMRs") pursuant to its Performance Share Plan ("PSP") vested on 24 February 2025 following satisfaction of performance conditions measured over the three year period to 31 December 2024.
Each PDMR received vested ordinary shares (after deduction of shares for payroll taxes) on 26 February 2025. The market price per ordinary share in the Company used to calculate the amount payable to the PDMRs and the amount of shares to be issued to PDMRs was 144.6 pence, being the average closing price of the Company's shares over the three-trading day period immediately preceding the vesting date, and the exchange rate used to calculate the cash payment and amount of share settlement was £1: $1.26.
PDMR Notification
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Bharatt Chowrira Eric Elenko |
| 2 | Reason for the notification | |
| a) | Position/status | Bharatt Chowrira - Chief Executive Officer Eric Elenko - President |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| c) | Price(s) and volume(s) | Recipient Price Amount Bharatt Chowrira 0.01 GBP 108,103 ordinary shares Eric Elenko 0.01 GBP 118,710 ordinary shares |
| e) | Date of the transaction | 26 February 2025 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.